诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09969 诺诚健华

未开盘 12-23 16:08:41

5.930

+0.000

0.00%

最高5.970	最低5.800	成交量208.80万
今开5.820	昨收5.930	日振幅2.87%
总市值104.52亿	流通市值88.71亿	总股本17.63亿
成交额1,230万	换手率0.14%	流通股本14.96亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09969","market":"HK","secType":"STK","nameCN":"诺诚健华","latestPrice":5.93,"timestamp":1734941321016,"preClose":5.93,"halted":0,"volume":2088000,"delay":0,"floatShares":1496000000,"shares":1762567202,"eps":-0.39339775,"marketStatus":"未开盘","marketStatusCode":0,"change":0,"latestTime":"12-23 16:08:41","open":5.82,"high":5.97,"low":5.8,"amount":12298920,"amplitude":0.028668,"askPrice":5.93,"askSize":10000,"bidPrice":5.88,"bidSize":23000,"shortable":3,"etf":0,"ttmEps":-0.23320511922521095,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735003800000},"adr":0,"listingDate":1584892800000,"adjPreClose":5.93,"openAndCloseTimeList":[[1734917400000,1734926400000],[1734930000000,1734940800000]],"volumeRatio":0.6656970275330845,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"诺诚健华","latestPrice":12.1,"timestamp":1734937200000,"preClose":12.61,"halted":0,"volume":5031573,"delay":0,"premium":"-53.91"}},"requestUrl":"/m/hq/s/09969","defaultTab":"news","newsList":[{"id":"2492148164","title":"诺诚健华（688428）12月18日主力资金净卖出1354.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492148164","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492148164?lang=zh_cn&edition=full","pubTime":"2024-12-19 08:24","pubTimestamp":1734567894,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月18日收盘，诺诚健华报收于12.91元，下跌1.83%，换手率1.67%，成交量4.45万手，成交额5778.72万元。近5日资金流向一览见下表：诺诚健华融资融券信息显示，融资方面，当日融资买入419.98万元，融资偿还877.4万元，融资净偿还457.43万元。诺诚健华主营业务：创新药的研发、生产及商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121900007782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","688428","BK0239","09969","BK1574"],"gpt_icon":0},{"id":"2492927910","title":"诺诚健华授出987.02万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2492927910","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492927910?lang=zh_cn&edition=full","pubTime":"2024-12-18 08:15","pubTimestamp":1734480900,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　诺诚健华（09969）发布公告，于今日收市及股东特别大会结束后，公司已根据2024年人民币股份激励计划作出首次授予，向79名激励对象授予987.02万股限制性股票，占本公告日期公司已发行股份总数约0.56%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-18/doc-inczvssx8331896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK1161","BK1574","09969","688428"],"gpt_icon":0},{"id":"2492295187","title":"诺诚健华(09969)授出987.02万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2492295187","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492295187?lang=zh_cn&edition=full","pubTime":"2024-12-17 20:44","pubTimestamp":1734439462,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺诚健华(09969)发布公告，于今日收市及股东特别大会结束后，公司已根据2024年人民币股份激励计划作出首次授予，向79名激励对象授予987.02万股限制性股票，占本公告日期公司已发行股份总数约0.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09969","BK1574","BK1161","688428","BK0239"],"gpt_icon":0},{"id":"2492959065","title":"诺诚健华首次授予987万股限制性股票 授予价6.65元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492959065","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492959065?lang=zh_cn&edition=full","pubTime":"2024-12-17 20:18","pubTimestamp":1734437880,"startTime":"0","endTime":"0","summary":"根据公告，限制性股票首次授予日为2024年12月17日，授予数量为987万股，约占公司已发行股份总数17.63亿股的0.56%。本次激励计划采用第二类限制性股票，授予价格为6.65元/股，涉及79名符合条件的激励对象。根据会计准则，首次授予的限制性股票公允价值为13.15元/股，预计将产生总费用6936万元，分摊到2024年至2029年各年度的具体费用也已列出。2024年前三季度，诺诚健华-U实现收入6.98亿元，归母净利润-2.75亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217202552ab7f1709&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217202552ab7f1709&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","688428","BK1161","BK1574"],"gpt_icon":0},{"id":"2492953681","title":"诺诚健华(688428.SH)向79名激励对象授予987.02万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2492953681","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492953681?lang=zh_cn&edition=full","pubTime":"2024-12-17 19:51","pubTimestamp":1734436297,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺诚健华(688428.SH)发布公告，公司于2024年12月17日召开董事会审议通过了《关于向激励对象首次授予限制性股票的议案》，确定公司本次激励计划的首次授予日为2024年12月17日，以6.65元/股的授予价格向79名符合授予条件的激励对象授予987.02万股限制性股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226156.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688428","BK1161","BK1574","09969"],"gpt_icon":0},{"id":"2491695409","title":"信达、礼来再度牵手！BTK抑制剂新势力崛起，百济神州、诺诚健华等直面多方夹击？","url":"https://stock-news.laohu8.com/highlight/detail?id=2491695409","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491695409?lang=zh_cn&edition=full","pubTime":"2024-12-16 21:02","pubTimestamp":1734354167,"startTime":"0","endTime":"0","summary":"PD-1抑制剂合作虽然受阻，但信达生物和礼来选择在BTK抑制剂上继续携手前行。随着阿斯利康、礼来等竞争对手在临床试验中展现的出色数据，百济神州在BTK抑制剂领域面临的竞争压力日益增大。相比于第一代BTK抑制剂，第二代产品在脱靶不良反应方面总体来说具有较大改进。匹妥布替尼作为国内首个获批的非共价BTK抑制剂，为复发或难治性MCL成人患者提供了新的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216212310ab7c73ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216212310ab7c73ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","BK1161","LU2328871848.SGD","06160","LU0307460666.USD","LU1969619763.USD","09969","BK1588","LU0588546209.SGD","BK1574","BK1583"],"gpt_icon":0},{"id":"2491317051","title":"诺诚健华盘中异动 大幅下挫5.13%报6.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491317051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491317051?lang=zh_cn&edition=full","pubTime":"2024-12-13 15:40","pubTimestamp":1734075639,"startTime":"0","endTime":"0","summary":"2024年12月13日临近收盘15时40分，诺诚健华股票出现异动，股价大幅下挫5.13%。截至发稿，该股报6.100港元/股，成交量756万股，换手率0.51%，振幅5.29%。资金方面，该股资金流入1782.32万港元，流出2176.19万港元。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。诺诚健华股票所在的生物技术行业中，整体跌幅为1.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213154039ab74a9c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213154039ab74a9c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","688428","BK1161","09969"],"gpt_icon":0},{"id":"2490743804","title":"诺诚健华12月09日主力资金流出109万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2490743804","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490743804?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:16","pubTimestamp":1733732166,"startTime":"0","endTime":"0","summary":"12月09日，诺诚健华股价收平报6.65元，成交金额1901万元，换手率0.19%，振幅4.06%，量比0.68。诺诚健华今日主力资金净流出109万元，连续3日净流出，上一交易日主力净流出168万元，今日环比减少35.12%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为60.00%，平均跌幅为2.88%。该股近5个交易日下跌0.30%，主力资金累计净流出236万元；近20日主力资金累计净流入1559万元，其中净流入天数为12日。该股主力净额占比0.01%，港股市场排名2476/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209161632ab694213&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209161632ab694213&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09969"],"gpt_icon":0},{"id":"2489725401","title":"诺诚健华12月06日遭主力抛售168万元 环比增加118.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489725401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489725401?lang=zh_cn&edition=full","pubTime":"2024-12-06 16:15","pubTimestamp":1733472935,"startTime":"0","endTime":"0","summary":"12月06日, 诺诚健华股价跌0.60%，报收6.65元，成交金额2330万元，换手率0.23%，振幅3.74%，量比0.82。诺诚健华今日主力资金净流出168万元，上一交易日主力净流出77万元，今日环比增加118.18%。该股近5个交易日上涨2.31%，主力资金累计净流出138万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2030万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206161553ab6206e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206161553ab6206e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09969"],"gpt_icon":0},{"id":"2489788111","title":"诺诚健华（688428）12月4日主力资金净卖出245.74万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489788111","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489788111?lang=zh_cn&edition=full","pubTime":"2024-12-05 08:21","pubTimestamp":1733358081,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月4日收盘，诺诚健华报收于14.17元，下跌5.41%，换手率2.56%，成交量6.82万手，成交额9855.77万元。近5日资金流向一览见下表：诺诚健华融资融券信息显示，融资方面，当日融资买入543.7万元，融资偿还977.62万元，融资净偿还433.92万元。诺诚健华主营业务：创新药的研发、生产及商业化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120500007040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","688428","09969","BK0239","BK1574"],"gpt_icon":0},{"id":"2488569041","title":"12月4日诺诚健华-U跌5.41%，鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488569041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488569041?lang=zh_cn&edition=full","pubTime":"2024-12-04 16:09","pubTimestamp":1733299740,"startTime":"0","endTime":"0","summary":"证券之星消息，12月4日诺诚健华-U跌5.41%，收盘报14.17元，换手率2.56%，成交量6.82万手，成交额9855.77万元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共17家，其中持有数量最多的公募基金为鹏华医药科技股票A。鹏华医药科技股票A目前规模为25.32亿元，最新净值1.1408，较上一交易日下跌0.05%，近一年下跌4.54%。鹏华医药科技股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120400027511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","BK1515","09969","688428","BK0239","BK1161","159938","BK1574"],"gpt_icon":0},{"id":"2488907400","title":"南向资金12月3日净买入诺诚健华15.60万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2488907400","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488907400?lang=zh_cn&edition=full","pubTime":"2024-12-04 09:30","pubTimestamp":1733275817,"startTime":"0","endTime":"0","summary":"12月3日, 南向资金增持诺诚健华15.60万股，连续3日增持。截止当日收盘，港股通共持有诺诚健华27311.78万股，占流通股15.48%。港股通增持金额前五个股分别为美团-W、阿里巴巴-W、中国移动、腾讯控股、招商银行。诺诚健华近5个交易日上涨12.66%，港股通累计增持103.19万股；近20个交易日上涨1.31%，港股通累计增持1382.39万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204093254abf426b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204093254abf426b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688428","09969"],"gpt_icon":0},{"id":"2488954333","title":"诺诚健华现涨逾5% 近期公布2024年科创板限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2488954333","media":"新浪港股","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488954333?lang=zh_cn&edition=full","pubTime":"2024-12-03 11:38","pubTimestamp":1733197080,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　诺诚健华（09969）早盘上涨4.95%，现报7.00港元，成交额2996.95万港元。\n　　诺诚健华近期公布2024年科创板限制性股票激励计划，拟向激励对象授予的限制性股票数量为1233.775万股。本计划限制性股票的授予价格（含预留授予）为每股6.65元。\n　　西南证券认为，较快的业绩增速彰显了公司未来的发展信心。该行指，诺诚健华业绩成长确定性强，管线落地在即，预计2024-2026年营业收入分别为10.1、15.4、20.9亿元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-12-03/doc-incycyiz1831349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09969","BK1574","688428","BK0239","BK1161","159982"],"gpt_icon":0},{"id":"2488930581","title":"港股异动 | 诺诚健华(09969)涨超5% 股权激励彰显公司发展信心 自免和实体瘤管线拓展顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=2488930581","media":"智通财经","labels":["executive","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488930581?lang=zh_cn&edition=full","pubTime":"2024-12-03 11:29","pubTimestamp":1733196584,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺诚健华涨超5%，截至发稿，涨5.25%，报7.02港元，成交额2963.32万港元。消息面上，诺诚健华近期公布2024年科创板限制性股票激励计划，拟向激励对象授予的限制性股票数量为1233.775万股。西南证券认为，较快的业绩增速彰显了公司未来的发展信心。该行指，诺诚健华业绩成长确定性强，管线落地在即，预计2024-2026年营业收入分别为10.1、15.4、20.9亿元。自免和实体瘤管线拓展顺利，创新管线有望未来1-3 年内陆续上市，维持诺诚健华“增持”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09969","BK1161","688428","BK0239","BK1574"],"gpt_icon":0},{"id":"2488930823","title":"诺诚健华盘中异动 急速上涨5.10%报7.010港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488930823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488930823?lang=zh_cn&edition=full","pubTime":"2024-12-03 11:19","pubTimestamp":1733195976,"startTime":"0","endTime":"0","summary":"2024年12月03日早盘11时19分，诺诚健华股票出现波动，股价大幅上涨5.10%。截至发稿，该股报7.010港元/股，成交量363.8万股，换手率0.24%，振幅5.70%。资金方面，该股资金流入1253.28万港元，流出756.187万港元。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。诺诚健华股票所在的生物技术行业中，整体跌幅为0.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120311193698e50417&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120311193698e50417&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1574","688428","BK1161"],"gpt_icon":0},{"id":"2486315327","title":"诺诚健华：12月17日将召开2024年第一次临时股东大会（股东特别大会）","url":"https://stock-news.laohu8.com/highlight/detail?id=2486315327","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486315327?lang=zh_cn&edition=full","pubTime":"2024-11-28 20:37","pubTimestamp":1732797452,"startTime":"0","endTime":"0","summary":"证券日报网讯11月28日晚间，诺诚健华发布公告称，公司将于2024年12月17日召开2024年第一次临时股东大会（股东特别大会）。本次股东大会将审议《审议及批准采纳2024年人民币股份激励计划及计划授权上限》《审议及批准采纳激励计划考核管理办法》《审议及批准建议根据计划授权上限发行及授出2024年人民币股份激励计划项下的新人民币股份》等多项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411283253931491.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2486364018","title":"诺诚健华11月28日主力资金流入83万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2486364018","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486364018?lang=zh_cn&edition=full","pubTime":"2024-11-28 16:15","pubTimestamp":1732781747,"startTime":"0","endTime":"0","summary":"11月28日, 诺诚健华股价跌0.15%，报收6.70元，成交金额3079万元，换手率0.31%，振幅2.83%，量比0.70。诺诚健华今日主力资金净流入83万元，连续3日净流入，上一交易日主力净流入597万元，今日环比减少86.10%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为75.00%，平均涨幅为2.52%。该股近5个交易日上涨2.91%，主力资金累计净流入765万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入2794万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128161603a25bdc2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128161603a25bdc2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09969"],"gpt_icon":0},{"id":"2486382221","title":"诺诚健华（688428）11月27日主力资金净卖出334.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486382221","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486382221?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:12","pubTimestamp":1732752736,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月27日收盘，诺诚健华报收于13.87元，上涨8.27%，换手率4.05%，成交量10.78万手，成交额1.48亿元。近5日资金流向一览见下表：诺诚健华融资融券信息显示，融资方面，当日融资买入699.46万元，融资偿还608.35万元，融资净买入91.11万元。诺诚健华主营业务：创新药的研发、生产及商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112800006194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","09969","BK0239","BK1574","688428"],"gpt_icon":0},{"id":"2486842079","title":"生物医药股多数走高！机构看好板块修复空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2486842079","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486842079?lang=zh_cn&edition=full","pubTime":"2024-11-27 18:37","pubTimestamp":1732703861,"startTime":"0","endTime":"0","summary":"11月27日，港股多数生物医药股走强。其中，科伦博泰生物-B(06990.HK)大涨10.11%，诺诚健华(09969.HK)涨8.93%，荃信生物-B（02509.HK）涨8.57%，科济药业-B（02171.HK）涨7.73%，百济神州（06160.HK）涨7.21%，金斯瑞生物科技（01548.HK）涨4.96%。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202411_1/1cfe0a94-093d-40f9-9aa9-6ac7e40e346c.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202411_1/1cfe0a94-093d-40f9-9aa9-6ac7e40e346c.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6746f675bde0b3216fc904f4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":[".SPX","BK1583","SH","BK4077","LU1969619763.USD","02509","US5Y.BOND","US3Y.BOND","SDS","BK1587","US10Y.BOND","BK4504","OEF","LU0588546209.SGD","BK1141","US12M.BOND","BK1161","LU2328871848.SGD","BK1500","BK4550","BK4585","OEX","HK0000934320.USD","US30Y.BOND","HK0000320223.HKD","US6M.BOND","HK0000306685.HKD","US2Y.BOND","ESmain","06990","SPY","SPXU","02171","LU0196878994.USD","SSO","BK1576","US7Y.BOND","IVV","09969","HK0000306701.USD","BK1574","BK1585","FOMC","06160","UPRO","BK4581","BK1588","01548","BK4534","BK4588"],"gpt_icon":0},{"id":"2486131668","title":"港股生物医药股午后放量大涨，科伦博泰生物(06990.HK)张近10%，诺诚健华(09969.HK)涨超8.5%，百济神州(06160.","url":"https://stock-news.laohu8.com/highlight/detail?id=2486131668","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486131668?lang=zh_cn&edition=full","pubTime":"2024-11-27 15:16","pubTimestamp":1732691817,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["09995","161726","BK1576","LU1969619763.USD","BK4505","688428","03347","LU0307460666.USD","LU1064131003.USD","BK0028","688331","BK0239","LU1146622755.USD","BGNE","LU2148510915.USD","BK4585","SG9999014674.SGD","06990","BK0077","06160","BK0216","BK1141","BK1588","BK4504","BK4588","HSCEI","688235","300347","BK0174","LU1820825898.SGD","BK4535","BK1583","HSTECH","02268","399441","09969","YANG","BK4139","BK1161","LU1064130708.USD","BK4548","LU2328871848.SGD","BK1574","BK4526","07226","LU0196878994.USD","BK1500","LU0588546209.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"https://cn.innocarepharma.com","stockEarnings":[{"period":"1week","weight":-0.0358},{"period":"1month","weight":-0.0373},{"period":"3month","weight":0.1084},{"period":"6month","weight":0.2617},{"period":"1year","weight":-0.0749},{"period":"ytd","weight":-0.1393}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0464},{"period":"6month","weight":0.0991},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.1663}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"诺诚健华医药有限公司是一家主要从事生物医药研发、生产和商业化的中国公司。该公司专注于肿瘤和自身免疫性疾病等存在巨大未满足临床需求的领域。该公司的主要产品管线包括奥布替尼、Tafasitamab、ICP-490、ICP-B02、ICP-248、ICP-B05、ICP-332、ICP-488、ICP-192、ICP-723、ICP-033和ICP-189等。其产品主要用于治疗血液瘤、实体瘤和自身免疫病。该公司还在开发用于治疗由B细胞或T细胞功能异常所导致的自身免疫性疾病的产品。该公司主要在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.120109},{"month":2,"riseRate":0.5,"avgChangeRate":0.019126},{"month":3,"riseRate":0,"avgChangeRate":-0.043789},{"month":4,"riseRate":0.6,"avgChangeRate":0.117148},{"month":5,"riseRate":0,"avgChangeRate":-0.072765},{"month":6,"riseRate":0.8,"avgChangeRate":0.122586},{"month":7,"riseRate":0.4,"avgChangeRate":-0.028005},{"month":8,"riseRate":0.2,"avgChangeRate":-0.086099},{"month":9,"riseRate":0.2,"avgChangeRate":-0.051427},{"month":10,"riseRate":0.4,"avgChangeRate":0.007797},{"month":11,"riseRate":0.8,"avgChangeRate":0.112999},{"month":12,"riseRate":0.6,"avgChangeRate":0.012989}],"exchange":"SEHK","name":"诺诚健华","nameEN":"INNOCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺诚健华(09969)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺诚健华,09969,诺诚健华股票,诺诚健华股票老虎,诺诚健华股票老虎国际,诺诚健华行情,诺诚健华股票行情,诺诚健华股价,诺诚健华股市,诺诚健华股票价格,诺诚健华股票交易,诺诚健华股票购买,诺诚健华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺诚健华(09969)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}